https://markets.businessinsider.com/news/stocks/lipella-pharmaceuticals-to-present-phase-2a-data-for-lp-310-in-oral-lichen-planus-at-2025-aaom-eaom-international-meeting-1034730380
Lipella Pharmaceuticals to Present Phase 2a Data for LP-310 in Oral Lichen Planus at 2025 AAOM/EAOM...
Statistically significant safety and efficacy data from 0.25 mg and 0.50 mg cohorts to be presentedPresentation scheduled for Thursday, May 15, 20...